companydata.dkcompanydata.dk
SearchPricingAPI
companydata.dkcompanydata.dk

Free company lookup with financials, ownership and key figures for all Danish companies.

Overview

  • Municipalities
  • Postal codes
  • Industries
  • Countries
  • Top 100 companies
  • Top lists
  • Business news
  • Check company
  • Find owner
  • Financial data
  • Credit rating
  • Credit report
  • Background check

Links

  • Search
  • Pricing
  • Company profile
  • Monitoring
  • Lead List Generator
  • CVR Enrichment
  • Network search
  • Statstidende
  • Guides
  • Glossary
  • Compare alternatives

Integrations

  • API
  • MCP-server
  • Claude
  • ChatGPT
  • Perplexity
  • Mistral Le Chat
  • Gemini
  • Zapier
  • Dinero
  • e-conomic

Who it's for

  • For accountants
  • For investors
  • For sales teams
  • For lawyers
  • For journalists

Legal

  • Privacy Policy
  • Terms of Service
  • Information Letter
  • Contact

© 2026 companydata.dk

Thue Walter Schwartz

PersonUnit number: 4004004150
Frederiksberg C
3
Ownership
9
Board positions
2
Director positions
4
Other roles
85
People in network
1
Bankruptcy relations

People in network(85)

People who held roles at the same companies, or who co-own the same companies

Florian Schønharting
PROFOUND INVEST A/S, NUEVOLUTION A/S, NORDIC BIOTECH INCENTIVE ApS, NORDIC BIOTECH INCENTIVE ApS, NORDIC BIOTECH PRIVATE INVESTORS ApS, NORDIC BIOTECH PRIVATE INVESTORS ApS, ROSE PHARMA A/S
Peter Moldt
NTG Nordic Transport Group A/S, 7TM A/S, 7TM A/S, PROFOUND INVEST A/S, NUEVOLUTION A/S, NORDIC BIOTECH PRIVATE INVESTORS ApS
Jan Møller Mikkelsen
PROFOUND INVEST A/S, PROFOUND INVEST A/S, 7TM A/S, NUEVOLUTION A/S
Find the connection to another person

Ownership(3)

NORDIC BIOTECH INCENTIVE ApS
CVR: 26277779
EJERREGISTER
Under liquidation
10-14,99%
Ownership
Active
NORDIC BIOTECH PRIVATE INVESTORS ApS
CVR: 26284384
EJERREGISTER
Under liquidation
5-9,99%
Ownership
Active
Receptor Holding ApS
CVR: 39115476
EJERREGISTER
100%
Ownership
Active

Board positions(1)

Solid Therapeutics ApS
CVR: 43007068
BESTYRELSESMEDLEM
Active
Since 21. jan. 2022

Director positions(1)

Receptor Holding ApS
CVR: 39115476
ADM. DIR.
Active
Since 16. nov. 2017

Other roles(2)

Solid Therapeutics ApS
CVR: 43007068
STIFTERE
Active
Since 21. jan. 2022
Receptor Holding ApS
CVR: 39115476
STIFTERE
Active
Since 16. nov. 2017

Got a list of CVR numbers?

Enrich it with company names, key figures, owners and contact details in minutes.

Try CVR enrichment

Former board positions(8)

ROSE PHARMA A/S
CVR: 27174965
BESTYRELSE
Dissolved
Ended
Since 26. jun. 2003
Until 3. mar. 2004
NUEVOLUTION A/S
CVR: 26029708
BESTYRELSESMEDLEM
Ended
Since 28. nov. 2001
Until 12. maj 2003
7TM A/S
CVR: 25108523
BESTYRELSESMEDLEM
Dissolved
Ended
Since 12. feb. 2001
Until 5. sep. 2012
PROFOUND INVEST A/S
CVR: 25609964
formand
Dissolved
Ended
Since 19. okt. 2000
Until 26. nov. 2009
ZINC INVEST ApS
CVR: 25228154
DIREKTION
Dissolved
Ended
Since 16. jun. 2000
Until 1. okt. 2012
MAXYGEN ApS
CVR: 21637289
BESTYRELSE
Dissolved
Ended
Since 28. apr. 1999
Until 15. aug. 2000
NTG Nordic Transport Group A/S
CVR: 12546106
BESTYRELSESMEDLEM
Ended
Since 29. apr. 1996
Until 30. aug. 2000
INDUSTRIAL SOFTWARE ApS
CVR: 49751613
DIREKTION
Dissolved
Ended
Since 2. mar. 1973
Until 11. dec. 1996

Former director positions(1)

7TM A/S
CVR: 25108523
DIREKTØR
Dissolved
Ended
Since 10. okt. 2000
Until 10. okt. 2000

Former roles(2)

UNWIREDFACTORY A/S
CVR: 25563409
STIFTERE
Bankruptcy
Ended
Since 2. jul. 2000
Until 30. jun. 2005
MAXYGEN ApS
CVR: 21637289
STIFTERE
Dissolved
Ended
Since 19. apr. 1999
Until 28. apr. 1999

Indirect ownership(4)

Companies owned indirectly through ownership chains.

Solid Therapeutics ApS
CVR: 43007068
20-24,99%
Effective ownership
Depth: 1
Ownership path:
Receptor Holding ApS(100%)
→Solid Therapeutics ApS(20-24,99%)
Embark Holdings ApS
CVR: 44152223
20-24,99%
Effective ownership
Depth: 1
Ownership path:
Receptor Holding ApS(100%)
→Embark Holdings ApS(20-24,99%)
Embark Laboratories ApS
CVR: 44172410
15-19,99%
Effective ownership
Depth: 2
Ownership path:
Receptor Holding ApS(100%)
→Embark Holdings ApS(20-24,99%)
→Embark Laboratories ApS(90-99,99%)
Incipiam Pharma ApS
CVR: 44074214
10-14,99%
Effective ownership
Depth: 1
Ownership path:
Receptor Holding ApS(100%)
→Incipiam Pharma ApS(10-14,99%)